Identification and Characterization of TF-lncRNA Regulatory Networks Involved in the Tumorigenesis and Development of

Dingkang Xu1, Yufeng Guo2, Shixiong Lei1

  • 1Department of Neurosurgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Frontiers in Oncology
|February 14, 2022
PubMed

Insights

Researchers identified key long noncoding RNAs (lncRNAs) and transcription factors (TFs) involved in adamantinomatous craniopharyngioma (ACP) development. This study provides a valuable resource for understanding ACP tumorigenesis and potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genomics

Background:

  • Adamantinomatous craniopharyngioma (ACP) is a rare sellar region tumor.
  • The molecular mechanisms, particularly the roles of long noncoding RNAs (lncRNAs) and transcription factors (TFs), in ACP tumorigenesis are not well understood.

Purpose of the Study:

  • To identify and characterize lncRNAs and TFs that regulate pathways associated with ACP.
  • To establish a comprehensive regulatory network of TF-lncRNA interactions in ACP.

Main Methods:

  • Transcriptome sequencing of 12 human ACP and 5 control samples.
  • Development of an integrated algorithm to identify lncRNAs and TFs regulating ACP-related pathways.
  • Analysis of ChIP-Seq datasets to verify TF-lncRNA correlations and validation using RT-PCR and immunohistochemistry.

Main Results:

  • An integrated algorithm identified 266 ACP-related lncRNAs and 39 TFs.
  • Analysis revealed 1004 TF-lncRNA pairs potentially regulating ACP pathways, forming 232 TF-lncRNA networks.
  • Validation confirmed positive expression of TFs E2F2 and KLF5, and upregulation of lncRNA RP11-360P21.2 in ACP tissues.

Conclusions:

  • This study presents the first systematic investigation of the TF-lncRNA regulatory network in ACP.
  • The identified lncRNAs and TFs offer a valuable resource for understanding ACP pathogenesis.
  • These findings may guide future research into targeted therapies for ACP.